1. Long non‑coding RNA Fer‑1‑like family member 4 suppresses hepatocellular carcinoma cell proliferation by regulating PTEN in�vitro and in�vivo
    Xinyi Sun et al, 2018, Molecular Medicine Reports CrossRef
  2. UPR-Induced miR-616 Inhibits Human Breast Cancer Cell Growth and Migration by Targeting c-MYC
    Vahid Arabkari et al, 2023, International Journal of Molecular Sciences CrossRef
  3. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways
    Da-xuan Wang et al, 2017, Acta Pharmacologica Sinica CrossRef
  4. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T
    Yifeng Tao et al, 2020, Aging CrossRef
  5. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years
    Song Zhang et al, 2021, Briefings in Bioinformatics CrossRef
  6. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway
    Bo Lv et al, 2022, World Journal of Surgical Oncology CrossRef
  7. Long noncoding RNA TUSC7 inhibits cell proliferation, migration and invasion by regulating SOCS4 (SOCS5) expression through targeting miR-616 in endometrial carcinoma
    Xiaoling Wu et al, 2019, Life Sciences CrossRef
  8. MicroRNAs Affect Complement Regulator Expression and Mitochondrial Activity to Modulate Cell Resistance to Complement-Dependent Cytotoxicity
    Yaron Hillman et al, 2019, Cancer Immunology Research CrossRef
  9. COL4A1, negatively regulated by XPD and miR-29a-3p, promotes cell proliferation, migration, invasion and epithelial–mesenchymal transition in liver cancer cells
    H. Zhang et al, 2021, Clinical and Translational Oncology CrossRef
  10. Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring
    Sugandha Bhatia et al, 2017, Biochemical Journal CrossRef
  11. MiR-616 promotes the progression of pancreatic carcinoma by targeting OXR1
    Yi ZHOU et al, 2021, Minerva Medica CrossRef
  12. Comparison of Subtypes of Hepatocellular Adenoma to Hepatocellular Carcinoma and Non-Neoplastic Liver Tissue in Terms of PTEN Expression
    Grzegorz Szparecki et al, 2017, Folia Biologica CrossRef
  13. Regulation of PTEN expression by noncoding RNAs
    Wang Li et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
  14. MicroRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
    Seyed Mostafa Parizadeh et al, 2019, Current Drug Targets CrossRef
  15. How microRNAs affect the PD-L1 and its synthetic pathway in cancer
    Gholamreza Rezaei Danbaran et al, 2020, International Immunopharmacology CrossRef
  16. LOC285194 inhibits proliferation of human keratinocytes through regulating miR-616/GATA3 pathway
    Jin Lin et al, 2020, Molecular and Cellular Probes CrossRef
  17. Circular RNA circ-4099 is induced by TNF-α and regulates ECM synthesis by blocking miR-616-5p inhibition of Sox9 in intervertebral disc degeneration
    Hua Wang et al, 2018, Experimental & Molecular Medicine CrossRef
  18. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2)
    Yuqiang Xu et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  19. miR‑616 promotes breast cancer migration and invasion by targeting TIMP2 and regulating MMP signaling
    Chao Yuan, 2019, Oncology Letters CrossRef
  20. MiR-616-3p promotes angiogenesis and EMT in gastric cancer via the PTEN/AKT/mTOR pathway
    Zhen-Hua Wu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  21. MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7
    Danping Wang et al, 2017, Oncology Reports CrossRef
  22. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma
    Ning Wang et al, 2018, Biochimie CrossRef
  23. miR‑330‑3p suppresses liver cancer cell migration by targeting MAP2K1
    Zhe Jin et al, 2019, Oncology Letters CrossRef